Neutralizing antibody responses to SARS-CoV-2
Theodora Hatziioannou, Ph.D., Research Associate Professor- Rockefeller University
10 events found.
Events
-
-
Zoom Seminar Series
-
Fab-dimerized glycan-reactive antibodies; a new structural category of natural antibodies
Zoom Seminar SeriesBarton F. Haynes, M.D., Director, Duke Human Vaccine Institute, Frederic M. Hanes Professor of Medicine, Professor of Immunology and Global Health- Duke University Medical Center
-
-
Systems Serology to Define Humoral Correlates of Immunity to SARS-CoV-2
Zoom Seminar SeriesGalit Alter, Ph.D.- Professor of Medicine- HMS, Group Leader- The Ragon Institute of MGH, MIT and Harvard
-
Skin and Vaccine Biology
Zoom Seminar SeriesThomas S. Kupper, M.D., Fitzpatrick Professor and Chair, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School
-
Deloping a COVID-19 vaccine and ensuring that everyone can get it
FeaturedWhen will there be an effective vaccine for COVID-19? How will it work? And how will it be distributed? Jonathan Saltzman, the Globe's biotechnology and life sciences reporter, will interview a panel of specialists about what's happening in clinical trials of potential vaccines, how long testing will last, and how to make sure that everyone […]
-
Antigen specific adaptive responses to SARS CoV2
Zoom Seminar SeriesAlessandro Sette, Dr. Biol.Sci., La Jolla Institute for Immunology
-
Zoom Seminar Series
Zoom Seminar SeriesDr. Aleks Stanic-Kostic
-
New frontiers in SARS-CoV-2 functional genomics
Zoom Seminar SeriesNeville Sanjana, Ph.D., Core Faculty Member, New York Genome Center, Assistant Professor of Biology, New York University, Assistant Professor Neuroscience and Physiology, NYU School of Medicine
-
-
Systems Vaccinology
Zoom Seminar SeriesBali Pulendran, Ph.D., Violetta L. Horton Professor, Professor of Pathology, Professor of Microbiology and Immunology- Stanford School of Medicine
-
Adaptive immune responses to COVID-19
Zoom Seminar SeriesShane Crotty, Ph.D., Professor- Center for Infectious Disease and Vaccine Research- La Jolla Institute for Immunology (LJI), Adj. Professor, UCSD School of Medicine, Dept. of Medicine, Division of Infectious Diseases and Global Public Health
